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Screening for asymptomatic internal carotid artery
stenosis and aneurysm of the abdominal aorta:
Comparing the yield between patients with
manifest atherosclerosis and patients with risk
factors for atherosclerosis only
H. A. J. M. Kurvers, MD,a Y. van der Graaf, MD,b J. D. Blankensteijn, MD,a F. L. J. Visseren, MD,c and
B. C. Eikelboom, MD,a for the SMART Study Group,* Utrecht, The Netherlands
Objective: The purpose of this study was to investigate whether screening for internal carotid artery stenosis (ICAS) and
aneurysm of the abdominal aorta (AAA) is indicated in patients with either manifest atherosclerotic disease or with only
risk factors for atherosclerosis.
Study design: Data were obtained for 2274 patients enrolled in the SMART study, an ongoing single-center, prospective
cohort study of patients referred to our vascular center with manifest atherosclerotic disease (peripheral atherosclerotic
disease [PAD]; transient ischemic attack [TIA], stroke, or ICAS; AAA; angina pectoris; or myocardial infarction [MI])
or with only risk factors for atherosclerosis (diabetes mellitus, hypertension, hyperlipidemia). The presence of ICAS or
AAA was determined with duplex scanning and ultrasonography.
Results: The prevalence of ICAS 70% or greater is low in patients with risk factors for atherosclerosis only (1.8%-2.3%),
intermediate in patients with angina pectoris or MI (3.1%), and highest in patients with PAD (12.5%) or AAA (8.8%). The
prevalence of AAA 3 cm or larger is low in patients with risk factors for atherosclerosis only (0.4-1.6%), intermediate in
patients with angina pectoris or MI (2.6%), and highest in patients with PAD (6.5%) or TIA, stroke, or ICAS (6.5%). The
prevalence of AAA larger than 5 cm is low in all of the considered patient groups. The yield of screening can be optimized
through selection on the basis of simple patient characteristics. In patients with PAD, selecting those with advanced age
(>54 years) increased the prevalence of ICAS to 21.8%. Selecting patients with lower diastolic blood pressure (<83 mm
Hg) increased the prevalence of ICAS to 17.9%. In patients with both advanced age and lower diastolic blood pressure,
the prevalence of ICAS increased to 34.7%. Selecting patients with advanced age increased the prevalence of AAA 3 cm or
larger to 9.6%. In patients with TIA, stroke, or ICAS, selecting those with advanced age increased the prevalence of AAA
3 cm or larger to 8.2%. Selecting patients with taller stature (>169 cm) increased the prevalence of AAA 3 cm or larger
to 9.3%. In patients with advanced age and taller stature, the prevalence of AAA 3 cm or larger increased to 13.1%.
Conclusions: Screening for ICAS should be limited to patients referred with PAD or AAA, especially those with advanced
age or with low diastolic blood pressure. Screening for AAA should be limited to patients referred with PAD or with TIA,
stroke, or ICAS, particularly those with advanced age or tall stature. In patients referred with angina pectoris or MI and
those referred with only risk factors for atherosclerosis, screening cannot be endorsed. (J Vasc Surg 2003;37:1226-33.)
It is increasingly recognized that the arterial system
should be seen as a whole and that atherosclerosis affects
multiple organs simultaneously. Consequently, some pa-
tients with manifest atherosclerosis likely have asymptom-
atic atherosclerosis at other sites of the vascular system as
well. Likewise, some patients referred because of risk factors
for atherosclerotic disease may have asymptomatic athero-
sclerosis. Hence in both of these patient groups screening
likely will enable detection of asymptomatic atherosclerotic
disease, eg, internal carotid artery stenosis (ICAS) and
aneurysm of the abdominal aorta (AAA). With detection of
ICAS or AAA, selected patients can benefit from surgical
treatment. Carotid endarterectomy lowers the risk for
stroke in patients with asymptomatic stenosis of the carotid
artery by more than 60%.1,2 Similarly, the advantages of
elective surgery to treat AAA are clear; mortality is 2% to
6%, compared with about 50% with a ruptured AAA. The
results of several clinical trials suggest that exclusion of AAA
is indicated if there is rapid growth (1 cm/y) or large
diameter (5.5 cm or greater).3,4 An additional benefit of
screening for ICAS and AAA is that it enables identification
of patients in whom criteria for operative intervention are
not yet met but who may require repeated duplex scanning
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to monitor disease progression. Finally, early detection of
ICAS or AAA enables initiation of medical therapy that may
have a beneficial effect on progression of disease.
Screening for ICAS with duplex scanning and for AAA
with ultrasonography is noninvasive, with high sensitivity
and specificity.5,6 Although these screening techniques are
reliable, safe, and relatively inexpensive, they are not uni-
versally applied, mainly because of the low yield, especially
in mass screening, which renders them cost-ineffective. For
example, identifying candidates for carotid endarterectomy
with mass screening for carotid stenosis costs more per
quality-adjusted life-year than is usually considered accept-
able.7 Moreover, it is not known in which patient groups
the prevalence of ICAS or AAA is high enough to justify
screening. Prevalence of atherosclerotic disease as reported
by different screening studies demonstrates a 10-fold vari-
ation8; These discrepancies are most likely caused by differ-
ences in methods and diagnostic criteria used. Taken to-
gether, these considerations prompted us to study
prevalence of ICAS and AAA in patient groups with either
manifest atherosclerotic disease or risk factors for athero-
sclerosis only, using identical diagnostic techniques and
definitions of disease. In addition, we investigated whether
screening yield can be optimized with selection on the basis
of simple patient characteristics.
PATIENTS AND METHODS
Patients. Data were obtained for 2274 patients en-
rolled in the Second Manifestations of ARTerial disease
(SMART) study, a single-center, prospective cohort study
of patients referred to the Vascular Center of the University
Medical Center, Utrecht, The Netherlands. This hospital-
based population included patients consulting a vascular
specialist because of either manifestation of atherosclerotic
disease (ie, peripheral atherosclerotic disease [PAD]; tran-
sient ischemic attack [TIA], stroke, or ICAS; AAA; angina
pectoris or myocardial infarction [MI]) or because of only
risk factors for atherosclerotic disease (ie, diabetes mellitus,
hypertension, hyperlipidemia). All patients were referred
for the first time to our vascular center, usually by their
general practitioner or by other clinical specialists. Defini-
tions of enrollment diagnoses in the SMART study are
listed in Table I. The main purpose of the SMART study is
to screen for and consequently treat coexisting risk factors
for atherosclerotic disease. In addition, the prevalence of
coexisting vascular disease at other sites of the arterial
system is determined. All patients underwent baseline ex-
amination including a questionnaire on cardiovascular dis-
ease; assessment of height, weight, and blood pressure;
blood testing for glucose and lipid concentrations; and
ultrasound scanning of the abdominal aorta and carotid
arteries. The SMART study was approved by the Medical
Ethics Committee of the University Medical Center, Utre-
cht, and written consent was obtained from all participants.
No minimum age was required, but patients older than 79
years were excluded. Also excluded were patients with
terminal malignancy.
Methods. All 2274 patients were screened for the
presence of asymptomatic ICAS or AAA. The presence of
carotid stenosis was determined by means of color-assisted
duplex scanning of the carotid arteries. Carotid artery ste-
nosis were graded according to measured peak systolic
velocity.9 Stenosis 70% or greater of the internal carotid
artery was considered present if PSV was 210 cm/s or
greater. AAA was defined as local dilatation of the aorta
with an anteroposterior diameter 3 cm or larger, including
thrombus mass, if any, seen on scans obtained in the sagittal
plane during systole. All duplex scanning and ultrasonog-
raphy was performed by well-trained registered vascular
technologists in a certified vascular laboratory.
Data analysis. Continuous variables are expressed as
mean and standard deviation according to the referral
diagnosis. Associations between age, height, weight, body
mass index, blood pressure, cholesterol and glucose con-
Table I. Definitions of enrollment diagnosis in Second
Manifestation of ARTerial (SMART) disease study
Enrollment diagnosis Definition
Internal carotid artery
stenosis
Asymptomatic carotid artery stenosis
with diameter reduction 30% (peak
systolic velocity 100 cm/s)
Abdominal aortic
aneurysm
Distal aortic anteroposterior diameter
3 cm, measured with
ultrasonography
Peripheral arterial
disease
Resting ABPi 0.9 or postexercise ABPi
decreased 20% in at least one leg,
with signs of intermittent claudication,
rest pain, or gangrene or ulcer
Transient ischemic
attack or minor
ischemic stroke
According to criteria established by
neurologist
Angina pectoris Chest pain with or without documented
ischemia on ECG and with
documented stenoses at angiography
(in practical terms, percutaneous
transluminal coronary angioplasty
required)
Myocardial infarction At least two of the following:
Chest pain for at least 20 min and
not disappearing after
administration of nitrates
ST elevation 1 mm in two
following leads or left bundle
branch block on ECG
CK level elevation of at least twice
normal value of CK and MB
fraction 5% of total CK level
Diabetes mellitus Fasting plasma glucose level 7.0
mmol/L, nonfasting serum glucose
level 11.1 mmol/L, or use of oral
antidiabetic drug or insulin
Hypertension Systolic blood pressure 160 mm Hg,
diastolic blood pressure 95 mm Hg,
or use of antihypertensive drugs
Hyperlipidemia Total cholesterol 6.5 mmol/L,
triglycerides 2.3 mmol/L, HDL
cholesterol 1.0 mmol/L, or use of
lipid-lowering drugs
ABPi, Ankle brachial pressure index; ECG, electrocardiogram; CK, creatine
kinase; MB, myocardial brand; HDL, high-density lipoprotein.
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centrations, sex, and smoking and between asymptomatic
ICAS 70% or greater and AAA 3 cm or larger were evalu-
ated with logistic regression analysis (SPSS for Windows
10; SPSS, Chicago, Ill) after continuous variables were
divided in tertiles, which enables easy interpretation of the
results. Variables with a significance level of P  .25 at
univariate analyses were entered into a multivariate logistic
regression model. Patient characteristics independently as-
sociated with ICAS or AAA at a significance level of P .05
were kept in the final model. Thus we determined which
patient characteristics were independently associated with
ICAS 70% or greater or AAA 3 cm or larger at a significance
level of P  .05. Finally, the proportion of patients with
characteristics associated with ICAS or AAA was calculated,
as was prevalence of ICAS or AAA in these patient catego-
ries.
RESULTS
Of the 2274 patients enrolled, 1520 had manifest
atherosclerotic disease (PAD, n  403; TIA, stroke, or
ICAS, n 459; AAA, n 147; angina pectoris or MI, n
511). The remaining 754 patients had only risk factors for
atherosclerotic disease (diabetes mellitus, n  224; hyper-
tension, n  259; hyperlipidemia, n  271).
Baseline characteristics of the study population per
referral diagnosis are presented in Table II. Patients with
risk factors for atherosclerosis were approximately 14 years
younger than those with manifest atherosclerosis.
Prevalence of ICAS 70% or greater was 12.5% for
patients with PAD, 8.8% for patients with AAA, 3.1% for
patients with angina pectoris or MI, 1.8% for patients with
diabetes mellitus, 2.3% for patients with hypertension, and
2.2% for patients with hyperlipidemia. Prevalence of AAA 3
cm or larger was 5.6% for patients with PAD, 5.6% for
patients with TIA, stroke, or ICAS, 2.6% for patients with
angina pectoris or MI, 1.4% for patients with diabetes
mellitus, 1.6% for patients with hypertension, and 0.4% for
patients with hyperlipidemia. Prevalence of AAA larger
than 5 cm was much lower: 0.8% for patients with PAD,
0.7% for patients with TIA, stroke, or ICAS, 0.2% for
patients with angina pectoris or MI, and 0% for patients
with diabetes mellitus, hypertension, or hyperlipidemia.
Results of univariate logistic regression analysis are
shown in Tables III and IV. Associations between patient
characteristics and ICAS 70% or greater (Table III) or AAA
3 cm or larger (Table IV) are presented as odds ratio with
95% confidence interval. Patient characteristics associated
with ICAS 70% or greater or AAA at a significance level of
P  .25 are marked with an asterisk. In some cases odds
ratio could not be determined because for some referral
diagnoses the prevalence of ICAS or AAA was too low. As
a result, after categorization of patient groups in tertiles,
some patient categories did not contain any patients; hence
odds ratio could not be determined. In Tables III and IV,
this is indicated as not analyzable (NA). Likewise, because
the number of AAA larger than 5 cm detected during
screening was low (n  7), valid multivariance analysis
could not be performed for this patient category.
In patients with PAD, advanced age, shorter stature,
higher body mass index, lower diastolic blood pressure, and
history of smoking were associated with presence of ICAS
70% or greater (Table III). After multivariate logistic re-
gression analysis, advanced age and lower diastolic blood
pressure remained independently associated with ICAS
70% or greater at a significance level of P  .05. For age,
this association was observed for the intermediate (54-65
years) and oldest (65 years) age groups, compared with
the youngest (54 years) age group. For diastolic blood
pressure, the association was observed for both the low
(75 mm Hg) and intermediate (75-83 mm Hg) groups,
compared with the high (83 mm Hg) diastolic blood
pressure group. In patients with AAA, low glucose concen-
tration and low diastolic blood pressure were associated
with ICAS 70% or greater. After multivariate logistic re-
gression analysis, neither characteristic proved to be inde-
pendently associated. In patients with angina pectoris or
MI, taller stature and higher cholesterol concentration
were associated with ICAS 70% or greater. Neither charac-
Table II. Baseline characteristics of patients per referral diagnosis
PAD
TIA, stroke,
ICAS AAA
Angina pectoris
or MI Diabetes mellitus Hypertension Hyperlipidemia
Age (y) 60 (11) 62 (10) 68 (7) 58 (9) 50 (15) 50 (13) 46 (12)
Male sex (%) 64 75 95 82 53 48 57
Smoking, current or past (%) 90 83 93 76 58 60 66
Height (cm) 172 (9) 173 (9) 177 (7) 174 (8) 173 (10) 173 (1) 175 (10)
Weight (kg) 76 (14) 77 (12) 82 (12) 82 (12) 86 (20) 80 (17) 81 (16)
Body mass index 25.6 (4.1) 25.9 (3.4) 26.2 (3.1) 27.0 (3.4) 28.7 (6.4) 26.9 (5.0) 26.4 (4.1)
Systolic blood pressure
(mm Hg)
146 (21) 147 (20) 143 (17) 134 (19) 135 (17) 150 (22) 131 (15)
Diastolic blood pressure
(mm Hg)
79 (10) 80 (10) 83 (9) 77 (9) 77 (9) 90 (13) 77 (9)
Total cholesterol 6.0 (1.2) 5.7 (1.0) 5.7 (0.9) 5.4 (1.2) 5.5 (1.3) 5.8 (1.1) 7.3 (2.0)
Glucose 6.4 (2.1) 6.3 (2.1) 5.8 (0.9) 6.3 (2.3) 12.0 (5.1) 5.7 (1.5) 5.7 (1.6)
PAD, Peripheral arterial disease; TIA, transient ischemic attack; ICAS, internal carotid artery stenosis; AAA, abdominal aortic aneurysm; MI, myocardial
infarction.
Values represent mean and (SD).
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teristic proved to be independently associated. In patients
with diabetes mellitus, hypertension, or hyperlipidemia, no
characteristics were independently associated with ICAS
70% or greater.
In patients with PAD, advanced age, taller stature,
higher systolic blood pressure, higher diastolic blood pres-
sure, and male sex were associated with presence of AAA 3
cm or larger (Table III). After multivariate logistic regres-
sion analysis, only advanced age remained independently
associated with AAA. This association was observed for the
intermediate (54-65 years) and oldest (65 years) age
groups, compared with the youngest (54 years) age
group. In patients with TIA, stroke, or ICAS, advanced
age, taller stature, higher systolic blood pressure, higher
diastolic blood pressure, and male sex were associated with
AAA 3 cm or larger. After multivariate logistic regression
analysis, only advanced age and taller stature remained
independently associated with AAA 3 cm or larger. For age,
this association was observed for the intermediate (54-65
years) and oldest (65 years) age groups, compared with
the youngest (54 years) age group. For height (169-177
cm), the association was observed for the tallest (177 cm)
and intermediate (169-177 cm) height groups, compared
with the shortest (169 cm) group. In patients with angina
pectoris or MI or with diabetes mellitus, hypertension, or
hyperlipidemia, no characteristics were independently asso-
ciated with AAA 3 cm or larger.
In patients with PAD, overall prevalence of ICAS 70%
or greater was 12.5%. Selecting only patients with advanced
age increased prevalence to 21.8%, and selecting only pa-
tients with lower diastolic blood pressure increased preva-
lence to 17.9%. In patients with both advanced age and
lower diastolic blood pressure, prevalence increased to
34.7%.
In patients with PAD, overall prevalence of AAA 3 cm
or larger was 5.6%. Selecting patients with advanced age
increased prevalence to 9.6%. In patients with TIA, stroke,
or ICAS, overall prevalence of AAA 3 cm or larger was
Table III. Association between patient characteristics and ICAS 70% per referral diagnosis
PAD
(n  403)
AAA
(n  147)
Angina pectoris or MI
(n  511)
Diabetes mellitus
(n  224)
Hypertension
(n  259)
Hyperlipidemia
(n  271)
OP  12.5% OP  8.8% OP  3.1% OP  1.8% OP  2.3% OP  2.2%
Age (y) * NA NA * *
First tertile 1 1 1 1
Second tertile 4.7 (1.6-14.4) 1.4 (0.3-6.4) 1.8 (0.2-12.8) 0.9 (0.1-8.5)
Third tertile 8.8 (3.0-25.9) 2.3 (0.5-9.8) 3.8 (0.5-28.2) 7.5 (1.2-48.0)
Height * * NA NA
First tertile 1 1 1 1
Second tertile 1.3 (0.7-2.6) 1.1 (0.3-3.9) 2.0 (0.4-8.9) 2.2 (0.4-13.7)
Third tertile 0.5 (0.2-1.2) 0.4 (0.7-2.2) 2.9 (0.8-11.0) 0.7 (0.1-8.4)
Body mass index * NA NA NA
First tertile 1 1 1
Second tertile 1.6 (0.8-3.4) 0.8 (0.2-3.0) 1.0 (0.2-4.1)
Third tertile 1.4 (0.6-3.0) 0.8 (0.2-3.0) 1.5 (0.4-5.9)
Systolic blood pressure NA NA
First tertile 1 1 1 1
Second tertile 0.8 (0.4-1.8) 0.8 (0.2-3.6) 0.7 (0.2-2.7) 1.5 (0.2-10.8)
Third tertile 1.3 (0.7-2.7) 1.4 (0.4-5.5) 1.6 (0.5-5.3) 2.1 (0.2-24.2)
Diastolic blood pressure * * NA NA
First tertile 1 1 1 1
Second tertile 0.7 (0.3-1.3) 1.0 (0.3-3.5) 1.3 (0.3-5.1) 1.0 (0.1-11.7)
Third tertile 0.4 (0.2-0.8) 0.4 (0.1-1.9) 0.8 (0.2-3.7) 1.1 (0.1-12.7)
Total cholesterol * NA
First tertile 1 NA 1 1 1
Second tertile 1.4 (0.7-3.0) NA 0.6 (0.2-2.3) 2.3 (0.2-25.8) 1.1 (0.1-7.6)
Third tertile 1.4 (0.7-2.9) NA 2.6 (0.9-8.0) 2.0 (0.1-33.4) 0.9 (0.1-6.5)
Glucose * NA NA
First tertile 1 1 1 1
Second tertile 1.2 (0.6-2.5) 1.1 (0.3-3.9) 1.9 (0.5-7.4) 1.5 (0.2-10.6)
Third tertile 1.5 (0.7-3.2) 0.3 (0.1-1.8) 1.8 (0.4-7.8) 2.5 (0.3-18.4)
Sex NA
Male 1 1.5 (0.3-6.9) 1 1 1
Female 1.4 (0.7-2.6) 1 1.1 (0.2-8.3) 1.9 (0.3-10.6) 1.3 (0.3-6.7)
Smoking * NA NA
Ever 1.4 (0.9-2.1) 1.4 (0.4-4.9) 1.2 (0.2-7.4) 1.2 (0.5-2.7)
Never 1 1 1 1
ICAS, Internal carotid artery stenosis; PAD, peripheral arterial disease; AAA, abdominal aortic aneurysm; MI, myocardial infarction; OP, overall prevalence;
NA, not analyzable.
Data represent odds ratio with (95% confidence interval).
*Patient characteristic associated with ICAS at P  5.25.
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5.6%. Selecting only patients with advanced age increased
prevalence to 8.2%, and selecting only patients with taller
stature increased prevalence to 9.3%. In patients with both
advanced age and taller stature, prevalence increased to
13.1%.
DISCUSSION
This is the first study in a large number of patients, with
use of identical diagnostic techniques and definitions of
disease, in which results of screening for asymptomatic
ICAS and AAA are compared between patient groups with
either manifest atherosclerotic disease or only risk factors
for atherosclerosis. The yield of screening for ICAS 70% or
greater is low in patients with only risk factors for athero-
sclerosis, intermediate in those with angina pectoris or MI,
and high in patients with PAD or AAA. In line with these
findings, the yield of screening for AAA 3 cm or larger is
low in patients with only risk factors for atherosclerosis,
intermediate in those with angina pectoris or MI, and high
in patients with PAD or with TIA, stroke, or ICAS. The
yield of screening for AAA 5 cm or larger is low, both in
patients with manifest atherosclerotic disease and in those
with only risk factors for atherosclerosis.
The results of this study also indicate that the yield of
screening for ICAS or AAA can be optimized with selection
on the basis of simple patient characteristics such as age,
diastolic blood pressure, and height. In patients with PAD,
ICAS 70% or greater was independently associated with
advanced age and lower diastolic blood pressure, which
confirms the findings of previous studies.10-13 In patients
with PAD or with TIA, stroke, or ICAS, presence of AAA 3
cm or larger was independently associated with advanced
age and taller stature (patients with TIA, stroke, or ICAS
only). Again, these findings are in line with findings re-
ported by others.14-17 Because of the cross-sectional design
of this study, patient characteristics associated with in-
Table IV. Association between patient characteristics and AAA 3 cm per referral diagnosis
PAD
(n  403)
TIA, stroke, ICAS
(n  459)
Angina pectoris or MI
(n  511)
Diabetes mellitus
(n  224)
Hypertension
(n  259)
Hyperlipidemia
(n  271)
OP  5.6% OP  5.6% OP  2.6% OP  1.4% OP  1.6% OP  0.4%
Age (y) * * NA NA NA
First tertile 1 1 1
Second tertile 6.3 (0.8-52.2) 2.7 (0.3-23.1) 2.1 (0.1-34.8)
Third tertile 12.1 (1.6-93.3) 6.4 (0.9-48.5) 3.2 (0.2-51.6)
Height * * NA NA
First tertile 1 1 1 1
Second tertile 6.7 (1.5-30.6) 5.3 (1.1-24.7) 1.9 (0.4-8.8) 1.3 (0.1-21.4)
Third tertile 4.6 (1.0-22.1) 7.7 (1.7-34.9) 2.1 (0.5-8.4) 2.3 (0.2-26.0)
Body mass index NA NA
First tertile 1 1 1 1
Second tertile 1.6 (0.5-4.6) 1.1 (0.4-2.9) 0.6 (0.1-2.9) 1.8 (0.1-30.0)
Third tertile 0.6 (0.2-2.5) 0.8 (0.3-2.4) 1.5 (0.4-6.0) 2.1 (0.1-35.0)
Systolic blood pressure * * * NA
First tertile 1 1 1 1 1
Second tertile 2.3 (0.5-11.7) 4.1 (0.9-18.9) 0.7 (0.1-4.0) 1.4 (0.1-22.2) 5.1 (0.5-57.3)
Third tertile 4.2 (0.9-19.0) 3.2 (0.7-14.4) 5.5 (0.5-12.5) 1.7 (0.1-27.7) 1.5 (0.1-24.7)
Diastolic blood
pressure
* * * NA
First tertile 1 1 1 1 1
Second tertile 0.7 (0.2-2.3) 2.0 (0.6-6.7) 2.1 (0.5-9.0) 1 (0.06-16.3) 2.5 (0.2-29.0)
Third tertile 2.0 (0.7-5.6) 2.5 (0.8-8.2) 2.8 (0.6-12.7) 1.5 (0.1-25.3) 1.3 (0.1-14.5)
Total cholesterol * NA NA
First tertile 1 1 1 1
Second tertile 1.5 (0.6-4.2) 1.9 (0.7-5.7) 0.9 (0.2-4.7) 2.1 (0.2-23.9)
Third tertile 0.9 (0.3-2.5) 1.2 (0.4-3.7) 1.5 (0.3-7.6) 0.9 (0.1-15.0)
Glucose NA NA NA
First tertile 1 1 1
Second tertile 1.4 (0.4-4.1) 1.0 (0.4-2.9) 1.2 (0.3-5.5)
Third tertile 1.7 (0.6-4.9) 1.7 (0.6-4.5) 1.3 (0.3-5.3)
Sex * * NA NA NA NA
Male 6.0 (1.4-26.2) 8.6 (1.2-64.6)
Female 1 1
Smoking NA NA NA
Ever 1.6 (0.5-5.4) 1.5 (0.8-2.6) 1.3 (0.6-2.9)
Never 1 1 1
ICAS, Internal carotid artery stenosis; PAD, peripheral arterial disease; AAA, abdominal aortic aneurysm; MI, myocardial infarction; OP, overall prevalence;
NA, not analyzable.
Data represent odds ratio with (95% confidence interval.
*Patient characteristic associated with ICAS at P  5.25.
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creased prevalence of ICAS or AAA must be considered
markers for disease, not risk factors. More specifically, it is
unlikely that low diastolic blood pressure contributes to
development of carotid artery stenosis; rather, low diastolic
blood pressure should be considered an indicator of ad-
vanced atherosclerosis.18-20 This hypothesis is supported
by several studies. Bots et al.18 showed an association
between the intima-media thickness of the common carotid
artery and diastolic blood pressure. The intima-media
thickness was increased in subjects with diastolic blood
pressure less than 60 mm Hg, compared with that in
subjects with diastolic blood pressure between 60 and 69
mm Hg. Likewise, Witteman et al20 investigated the asso-
ciation between diastolic blood pressure and progression of
aortic atherosclerosis. After 9 years of follow-up, age-ad-
justed relative risk for substantial atherosclerotic progres-
sion in women with a decrease in diastolic blood pressure of
10 mm Hg or more was 2.5, compared with a reference
group of women with smaller decrease or no change in
diastolic blood pressure. These findings suggest that de-
creased diastolic blood pressure indicates vessel wall stiffen-
ing associated with atherosclerotic progression. The rela-
tion between advanced atherosclerosis and lower diastolic
blood pressure may also account for the observation that
lower diastolic blood pressure is a risk factor for reduced
survival.21-23
In patients with PAD, reported prevalence of ICAS
ranges from 14% to 28%,24-29 which is somewhat higher
than the 12.5% overall prevalence in patients with PAD in
our study. Likewise, in our study prevalence of ICAS was
1.8% to 2.3% in patients with only risk factors for athero-
sclerosis, somewhat lower than that reported by others for
these patients30 and for the general healthy population
aged 60 to 79 years.31 These discrepancies, among others,
may result from differences in definitions and methods used
by other investigators to define the study population (usu-
ally older) and degree of carotid stenosis (usually less). We
opted to screen for ICAS 70% or greater rather than lesser
degrees of stenosis, because the benefit of carotid endarter-
ectomy to treat asymptomatic carotid stenosis, if present,
has been established only for stenosis more than 60%.2
In patients with PAD, prevalence of AAA has been
reported ranging from 6.1% to 14%,32-34 which is in line
with prevalence of 6.5% in our study. In patients with TIA,
stroke, or ICAS, observed prevalence of AAA (6.5%) is
lower than previously reported prevalence of 20% in pa-
tients referred for evaluation of both symptomatic and
asymptomatic carotid artery disease.35 In patients with
hypertension, prevalence of AAA in our study (1.6%) is
somewhat lower than that reported by others.36,37 Again,
these discrepancies indicate the difficulty in comparing
results of different screening studies. As indicated by Wan-
hainen et al,8 prevalence of vascular disease as reported by
screening studies may demonstrate 10-fold variation. These
authors state that reported disease prevalence depends
greatly on methods and diagnostic criteria used and that
detailed defined criteria are necessary to enable comparison
between studies. A primary advantage of our study is that
identical diagnostic techniques and definitions of ICAS and
AAA were used, which enables better comparison of actual
disease prevalence between various patient groups.
Several studies have investigated whether screening for
ICAS and AAA is cost-effective. Disease prevalence of 4.5%
for ICAS and 4% for AAA is required to render screening
cost-effective.38,39 With these minimum prevalence values,
the findings of our study suggest that screening for ICAS
should be limited to patients with PAD or AAA, whereas
screening for AAA should be limited to patients with PAD
or with TIA, stroke, or ICAS. However, the minimum
disease prevalence required to render screening cost-effec-
tive depends on specificity of the screening test, rate of
complications (TIA or stroke, ruptured aneurysm) in pa-
tients not subjected to surgery, relative risk reduction of
surgery, perioperative complication rate, and cost of screen-
ing, among other factors. Hence it is likely that with our
method the minimum disease prevalence required to ren-
der screening cost-effective differs from that reported by
others.
We observed a large difference in prevalence of ICAS
and AAA between patients with either manifest atheroscle-
rotic disease or risk factors for atherosclerotic disease. Prev-
alence of ICAS and AAA increases with age40,41; hence the
observed difference may be explained in part because pa-
tients with manifest atherosclerosis were approximately 14
years younger than those with only risk factors for athero-
sclerotic disease.
An argument against ultrasonographic screening for
ICAS and AAA can be made because these phenomena are
easily detected at routine physical examination. However,
presence of carotid bruits is a poor predictor of the presence
of ICAS.42 Similarly, abdominal palpation has only moder-
ate overall sensitivity for detecting AAA, and is sensitive
only for diagnosis of AAA large enough to warrant elective
intervention in patients who do not have large girth.43
Apart from the simple patient characteristics evaluated
in this study, other patient characteristics also are associated
with ICAS and AAA. In a previous study we reported that
prevalence of AAA in brothers of patients with AAA is far
higher than in the overall male population of the same
age,44 which is in line with findings of other studies.45,46 It
is important to stress that these other patient characteristics
should be used in conjunction with other characteristics
associated with ICAS and AAA in this study.
In conclusion, although prevention of stroke and rup-
ture of AAA remains an important goal in the care of
patients with risk factors for atherosclerosis, the results of
this study suggest that screening should be limited to
patients at high risk. More specifically, screening for ICAS
70% or greater should be limited to patients with PAD or
AAA, especially in those with advanced age or low diastolic
blood pressure. Likewise, screening for AAA 3 cm or larger
should be limited to patients with PAD or with TIA, stroke,
or ICAS, particularly in those with advanced age or tall
stature. In contrast, in patients with angina pectoris or MI
and in patients with only risk factors for atherosclerosis,
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 6 Kurvers et al 1231
screening yield is low and the process is probably not
cost-effective, and hence cannot be endorsed.
The SMART Study Group consists of the following
members, all at University Medical Center Utrecht,
Utrecht, The Netherlands: A. Algra, MD, PhD, Julius
Center for Health Sciences and Primary Care, and Depart-
ment of Neurology; J. D. Banga, MD, PhD, Department of
Internal Medicine; B. C. Eikelboom, MD, PhD, Depart-
ment of Vascular Surgery; Y. van der Graaf, MD, PhD,
Julius Center for Health Sciences and Primary Care; D. E.
Grobbee, MD, PhD, Julius Center for Health Sciences and
Primary Care; P. P. Th. de Jaegere, MD, PhD, Department
of Cardiology; L. J. Kappelle, MD, PhD, Department of
Neurology; H. A. Koomans, MD, PhD, Department of
Nephrology; W. P. Th. M. Mali, MD, PhD, Department of
Radiology.
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